Conclusions. Sertoli cells secrete Somatomedin-C, in quantity compatible with an autocrine-paracrine role in the testis. Fibroblast Growth Factor (FGF) but not GH stimulates this secretion, as reported with fibroblasts.
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H. Benahmed*,A.H Horera*, n.h.Chauvin* and E.de We have r e c e n t l y reported t h a t l n t h e t e s t 1 3 porclne lmmature S e r t o l l c e l l s cultured In a serum-rrce deflned medlun, r e l e a s e Somatonedln C / mmunoreactlrre IGF 1 IlrSmC) stimulated by FGF but not by GH (Ann Endocrlnol 1985, 46, 287) In t h e p r e s e n t r e p o r t we show t h a t SmCIIGFl 1s a potent r e g u l a t o r of Le;dlg c e l l d l f f e r e n t l a t l o n P i e e f f e c t of SmC/IGF 1 on Le-fllg c e l l a c t 1 -n t 7 was studled ~n c u b a t l r q porclne Immature Leydlg c e l l s wlth a b l o s y n t h e t l c SuC ICSlp/IGFI exerted a dose a d t l n e dependent s t l m u l a t l r g e f f e c t on Leydig c e l l functlon wlth the maxlmal response obtalned a t 50 ng/ml a f t e r 48hrs trearuent SnC/IGFl Increased both LH/hCG b l n d l r q (x4-5) b a s a l ( x 4 j and hCG-stlmulsted (xlS 5) t e s t o s t e r o n e secretion
The s11ght e f f e c t -of SnC/IGFl (100ng/ml f o r 48hrs) on Leydlg c e l l r11mber ( x i 3 ) and DNA slynthesls ( X I 5 ) I n t h e comparison v l t h t h e h g h steroldogenlc e f f e c t support the concept t t~t SmC/IGFl a c t s a s a c y t o d l f f e r e n c l a t l v e f a c t o r r a t h e r t t a n a growth f a c t o r
The steroldogenlc a c t l o n or SuC/IGFI ws not suppressed by cytoslne arablnosrde C, a DlIh synthesis ~n t~l b~t o r , supportirg t h e concept of t h e c y t o d l f f e r e n c l a t~v e r o l e of t h l s p e p t l a e I n conclusion, t h e production by S e r t o l l c e l l s of 1rSruC/1I;Fl associated wlth t h e s t l m u l a t l r q e f r e c t of SnC/IGFl on steroldogenesls, suggest t h a t t h l s peptlde could be a n l n t r a t e s t l c u l a r regulator of ie-pilg c e l l d l f r e r e n t l a t l o n INSERM, HBpital Debrousse, 69322 Lyon, France.
SOMATOMEDIN-C (Sm-C) RECEPTORS IN CULTURED PIG LEYDIG CELLS (LC): CHARACTERIZATION AND REGULATION. ROLE OF Sm-C ON LC FUNCTIONS
Using affinity cross-linking we have shown the presence of Sm-C receptors (Cm-C-R) in cultured pig LC. The Sy-C-R were further characterized by competition binding (KD 1.10-MI. When LC were cultured in a chemically defined medium without hormones, the number of Sm-C-R varied from 10000 to 15000 sites/cell. Treatment of LC with hCG induced a 2 to 3 fold increase in Sm-C-R. This effect was (maximum effect after 48 h) and dose-dependent (ED50 -10-1%;
Moreover LC treatment with Sm-C for 3 days induced an increase of hCG receptors (4-6 fold) and of hCG responsiveness (CAMP and testosterone production) (8-10 fold) with ED50 of about 2 ngldl. In addition, Sm-C stimulated LC DNA synthesis (ED50 1 10 ng/ml). These results show : 1) LC contain specific Sm-C-R which are positively regulated by hCG ; 2) Sm-C increased both hCG receptors number and hCG steroidogenic responsiveness of LC. Since Sertoli cells secrete Sm-C (see Chatelain e t all our data strongly suggest that Sm-C might play a role in the paracrine regulation of LC. Therefore Sm-C could play a key role on the delayed puberty observed in children with isolated growth hormone deficiency.
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SERUM LEVELS OF SOMATOMEDINS AND SOMATOMEDIN BINDING PROTEIN IN PREGNANT WOMEN AND THEIR INFANTS
Serum levels of IGF-I, IGF-I1 and the low molecular form of somatomedin binding protein (SMBP) were determined in pregnant women and t h e i r infants. Longitudinal studies during pregnancy were performed in healthy women, women with GH deficiency (n=3) and women with diabetes or gestational diabetes (n=44). IGF-I, IGF-I1 and SMBP were determined by radioimmunoassays using polyclonal antibodies.
The serum levels of IGF-I and SMBP, but not IGF-11, increased during pregnancy in both healthy wonlen and women with diabetes.
In GH deficient women the levels rose t o normal pregnant levels.
The b i r t h weight percentile of the infants increased with the maternal IGF-I levels and decreased with the maternal SMBP levels. The r a t i o between maternal IGF-I and SMBP levels improved the correlation t o the b i r t h weight percentile. No correlation was found between the b i r t h weight and the isolated values of IGF-I, IGF-11, SMBP and C-peptide in cord blood. The IGF-I1 levels in cord blood from infants of diabetic womenwere 50% higher than those of nondiabetic women.
The correlation between maternal levels of the b i r t h weight of the infants indicates t h a t maternal IGF-I levels may play a role in the t r a n s f e r of nutrients t o the f e t u s . The elevated IGF-I1 levels in cord blood of infants of diabetic women suggest t h a t IGF-I1 could participate in the glucose homeostasis of the fetus. Hypopit. 12 51 * 6.0 500 i 65 9.8 + 0.6 In foetuses, IGF I levels were similar to those in cases of total GH deficiency. IGF I1 levels were on average 6.5 times those of IGF I . No correlation was seen between IGF levels and growth parameters estimated by ultrasounds. Western blot analysis of IGF-BPS showed that foetal serum contained smaller quantities than normal adult serum of 42 and 39 K MW forms (which in the adult appear chiefly in the,., 150 K [IGF-BPI complex) and large auantities of the 34 and 30 K forms, which have a selective i f f i n i t y for IGF I1 and are minor forms in adults. Such a pattern occurs in GH deficiencv. Conclusion : The profile of IGFs and IGF-BPS in foetal serum i s similar to that seen a f t e r birth when GH control i s absent. To investigate the regulation and physiological significance of SHBG in f e t a l l i f e , i t ' s distribution in maternal and f e t a l blood and in amniotic f l u i d was measured. In s p i t e of high circulating estrogens, the f e t a l SHBG-levels were 13.4-fold below the maternal blood-concentrations: 3.0 + 1.0 (SD) ug/ml (n = 62) versus 40.1 + 9.3 (SD) uglml (n = 64r. No significant difference was found regarding f e t a l sex in maternal and f e t a l blood: female 2.9 + 0.8 ug/ml (n = 29) and male 3.2 + 1.0 ug/ml (n = 33). In amniotic f l u i d the SHBG-concentration was 1.1 + 0.6 u g h 1 in female and 0.9 + 0.5 in male pregnancies. This difference i s not significant. After the sharp f a l l of estrogens postnat a l l y the maternal SHBG-concentration declined by 50% during t h e f i r s t puerperal week. In contrast, the SHBG-levels increased by almost loo% during the f i r s t week in the newborns of both sexes (5.6 + 1.8 ug/ml). These findings suggest, t h a t f e t a l and maternal SHBG-1 eve1 s a r e independently regulated. While maternal SHBG i s strongly influenced by circulating estrogens, the regulation in fetuses and newborns seems t o be controlled by mechanisms othe r than induction and suppression by estrogens and androgens. I t may be speculated, t h a t the low SHBG-levels during f e t a l l i f e a r e related t o the increased biological steroid a c t i v i t y during t h i s period. In contrast t o other studies the measurement of SHBG in amniotic f l u i d did not prove t o help identify f e t a l sex. Supported by the DFG, Grant No. Si 323/2-1
